$261 Million is the total value of INTERWEST VENTURE MANAGEMENT CO's 12 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| REAL | THE REALREAL | $149,903,000 | -22.6% | 6,704,080 | 0.0% | 57.52% | -8.1% | |
| AVDR | Buy | AVEDRO | $62,317,000 | +15.7% | 2,745,244 | +0.1% | 23.91% | +37.5% |
| MGNX | MACROGENICS INC | $13,708,000 | -24.8% | 1,074,316 | 0.0% | 5.26% | -10.7% | |
| STIM | NEURONETICS INC | $8,565,000 | -33.6% | 1,030,689 | 0.0% | 3.29% | -21.1% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $7,840,000 | -3.3% | 764,918 | 0.0% | 3.01% | +14.9% | |
| AGTC | APPLIED GENETIC TECHNOL CORP | $6,057,000 | +9.8% | 1,455,904 | 0.0% | 2.32% | +30.4% | |
| KALV | KALVISTA PHARMACEUTICALS INC | $4,510,000 | -47.6% | 388,766 | 0.0% | 1.73% | -37.8% | |
| HAIR | RESTORATION ROBOTICS INC | $3,481,000 | +6.6% | 5,355,786 | 0.0% | 1.34% | +26.6% | |
| CDTX | CIDARA THERAPEUTICS INC | $2,707,000 | +18.8% | 1,356,813 | 0.0% | 1.04% | +41.2% | |
| New | OBALON THERAPEUTICS INC | $738,000 | – | 380,224 | +100.0% | 0.28% | – | |
| GKOS | Buy | GLAUKOS CORP | $709,000 | +17.8% | 11,351 | +42.0% | 0.27% | +40.2% |
| XENE | XENON PHARMACEUTICALS INC | $75,000 | -8.5% | 8,293 | 0.0% | 0.03% | +11.5% | |
| OBLN | Exit | OBALON THERAPEUTICS INC | $0 | – | -3,552,239 | -100.0% | -0.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-10-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GLAUKOS CORP | 28 | Q3 2023 | 33.0% |
| EIGER BIOPHARMACEUTICALS INC | 24 | Q3 2022 | 17.7% |
| APPLIED GENETIC TECHNOL CORP | 24 | Q3 2022 | 6.7% |
| XENON PHARMACEUTICALS INC | 20 | Q3 2021 | 0.6% |
| CIDARA THERAPEUTICS INC | 19 | Q2 2021 | 4.5% |
| THE REALREAL | 18 | Q3 2023 | 62.6% |
| KALVISTA PHARMACEUTICALS INC | 17 | Q4 2020 | 10.8% |
| DARE BIOSCIENCE INC | 16 | Q3 2023 | 0.3% |
| MACROGENICS INC | 14 | Q1 2020 | 19.2% |
| PMV PHARMACEUTICALS INC | 13 | Q3 2023 | 67.5% |
View INTERWEST VENTURE MANAGEMENT CO's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 144 | 2024-02-27 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-07-21 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-25 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-04-13 |
| 13F-HR | 2022-01-25 |
| 13F-HR | 2021-10-19 |
View INTERWEST VENTURE MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.